Notice of Change to Description of NIGMS Interest in the S10 Funding Opportunity Announcements PAR-22-079, PAR-22-080, and PAR-22-081
Notice Number:
NOT-GM-22-029

Key Dates

Release Date:

January 19, 2022

Related Announcements

PAR-22-079 - High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

PAR-22-080 - Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

PAR-22-081 - Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to revise language pertaining to the description of NIGMS interest in the S10 funding opportunity announcements PAR-22-079 "High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)", PAR-22-080 "Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)", and PAR-22-081 "Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)".

Part 2. Section I. Funding Opportunity Description

Current language:

In parallel, NIGMS is especially interested in promoting participation of Institutional Development Award (IDeA) states and programs in the S10 Program. The IDeA program will provide co-funding for scientifically meritorious applications from IDeA states and encourage sharing and collaboration among institutions, programs, and states.

Revised anguage:

In parallel, NIGMS is especially interested in promoting participation of Institutional Development Award (IDeA) states and programs in the S10 Program through co-funding meritorious applications from IDeA states.

All other aspects of the FOAs remain the same.

Inquiries

Please direct all inquiries to:

Christina Liu, Ph.D.
National Institute Of General Medical Sciences (NIGMS)
Email: [email protected]